In the United States, approximately 186,400 people are expected to be diagnosed with leukemia, lymphoma, myeloma and other blood cancers this year, according to the American Cancer Society. Thousands more are already in treatment. In April 2022, some of the nation’s top experts will gather for the third Miami Cancer Institute Summit of Americas on Immunotherapies for Hematologic Malignancies to discuss the advances in immunologically and molecular based system therapies, new-targeted diagnostic and therapeutic strategies for lymphoma, myeloma and leukemia, the role and timing of hematopoietic cell transplantation and the latest on chimeric antigen receptor (CAR) — T-cell therapies.
“The speed at which the field is advancing is very encouraging,” said symposium director Guenther Koehne, M.D., Ph.D., deputy director of Miami Cancer Institute, part of Baptist Health, and chief of blood and marrow transplant and hematologic oncology and champion of the summit. “But to maintain our forward progress we must not do our research in silos. We must share so that we can build upon what we have learned.”
The program is being held April 8 and 9, 2022, featuring a powerhouse faculty that includes physicians from Memorial Sloan Kettering, Dana-Farber Cancer Institute, MD Anderson Cancer Center, Columbia University’s Herbert Irving Comprehensive Cancer Center, the Abramson Cancer Center at the University of Pennsylvania and other leading institutions. Approximately 300 physicians and other health care providers attended last year’s virtual summit.
“Treatments are becoming more sophisticated and every day we are learning more about how to target treatment to the individual,” Koehne said. “By discussing the most recent research, we move science forward, ultimately offering more options to patients and improving their outcomes.”
Miami Cancer Institute’s Blood and Marrow Transplantation program was launched in July of 2019. It hit the 100-patient milestone in just 18 months. In addition, in July of 2020, as the program continued to expand, Hope Tower opened on the Baptist Hospital campus, adjacent to the institute. With 39 private rooms on 6 Hope and 45 private rooms on 5 Hope dedicated for bone marrow and immunotherapy patients, the new facility gives patients who face lengthy hospital stays, because of their compromised immune systems, a spacious accommodation that includes a refrigerator, microwave, large bathroom and even room to exercise.
Dr. Guenther Koehne will share his research and the Miami Cancer Institute’s experience at the third annual Miami Cancer Institute Summit of Americas on Immunotherapies for Hematologic Malignancies, which will be held on April 8 and 9, 2022. Register for the event or learn more at cmeonline.baptisthealth.net/immunotherapy-symposium.
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services. Miami Cancer Institute is part of Baptist Health South Florida, the largest health care organization in the region, and is selected as Florida’s only member of the Memorial Sloan Kettering Cancer Alliance.*
*According to Baptist Health South Florida.